Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Cellular Response to Exponentially Increasing and Decreasing Dose Rates

Jay Solanki, Thomas Tritt, Jordan Pasternack, Julia Kim, Jason Domogauer, Nicholas Colangelo and Roger Howell
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1354;
Jay Solanki
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Tritt
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan Pasternack
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Kim
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Domogauer
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Colangelo
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roger Howell
1Radiology Rutgers New Jersey Medical School Newark NJ United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1354

Objectives The treatment of cancer using targeted radionuclide therapy is of interest to the radiation oncology field due to its potential for killing tumor cells while minimizing dose-limiting toxicities to normal tissue. Ionizing radiation emitted by targeted radionuclide therapy delivers radiation absorbed doses over protracted periods of time with continuously varying dose rates. As RIT becomes a more prominent part of cancer therapy, accurate models for predicting biologically effective dose (BED) or equieffective dose (EQD2α/β) will become essential. This study examines the radiobiological impact of the dose rate increase half-time during the uptake phase of the radiopharmaceutical.

Methods V79 Chinese hamster lung fibroblasts were irradiated acutely or with continuously varying dose rates with 137Cs γ-rays for 168 h. The following dose rate patterns were delivered: acute, monoexponentially decreasing (Td=64 h), and exponentially increasing and decreasing with different increase half-times (Ti=2 h and Td=64 h, Ti=8 h and Td=64 h, Ti=24 h and Td=64 h). Cell survival assays were carried out and surviving fractions were calculated.

Results Data obtained from survival assays demonstrated that increasing Ti leads to increasing cell sparing. Conventional dose response models (BED and EQD2α/β) were not able to fit the cell survival data; they underestimate both BED and EQD2α/β at high dose rates and overestimate both at low dose rates. Cell cycle analysis suggested that differences in radiosensitivity cannot be attributed to redistribution. Accordingly, the expressions for BED and EQD2α/β were modified empirically with an adaptive response function that fit the experimental data more accurately.

Conclusions Our experimental data demonstrates a marked increase in cell survival when the dose rate increase half-time is increased, thereby suggesting an adaptive response arising as a consequence of this phase of the irradiation. We have modified conventional radiobiological models to account for this phenomenon.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cellular Response to Exponentially Increasing and Decreasing Dose Rates
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cellular Response to Exponentially Increasing and Decreasing Dose Rates
Jay Solanki, Thomas Tritt, Jordan Pasternack, Julia Kim, Jason Domogauer, Nicholas Colangelo, Roger Howell
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1354;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cellular Response to Exponentially Increasing and Decreasing Dose Rates
Jay Solanki, Thomas Tritt, Jordan Pasternack, Julia Kim, Jason Domogauer, Nicholas Colangelo, Roger Howell
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1354;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Basic Science Posters

  • In Vivo PET/CT neuroimaging of radiolabeled nanocarriers following intranasal drug delivery (INDD): Validation using Ex Vivo PET/CT, gamma counting and autoradiography.
  • 18F-ML10 PET/CT demonstrates therapy-induced apoptosis in murine pancreatic adenocarcinoma
  • Relationship between the dynamic profile of LAT1 probe and tumoral blood flow: comparison study using 18F-FBPA, 18F-FAMT, and 15O-water PET
Show more MTA I: Basic Science Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire